Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab versus docetaxel after platinum failure in advanced non-small cell lung cancer
NL-OMON44833Phase 3Active, not recruiting
- Sponsor
- Roche
- Start
- Oct 2014
- Countries
- 1
01
Overview
Phase 3 trial, sponsored by Roche. Started Oct 2014; status: active, not recruiting.
Beyond the preview
Go deeper on NL-OMON44833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44833.